What interstitial lung diseases are associated with Crohn's disease (Crohn's) and at what typical age of onset?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Crohn's disease is associated with several interstitial lung diseases (ILDs), primarily including bronchiolitis, organizing pneumonia, granulomatous lung disease, and non-specific interstitial pneumonia, with a typical age of onset between 25 and 45 years. These pulmonary manifestations can develop at any time, but often occur after the intestinal disease has been established, as seen in a study of 11 patients with Crohn disease, where cough was among the presenting symptoms in six patients 1. The pathophysiology connecting Crohn's disease to these pulmonary manifestations involves shared immune dysregulation and inflammatory pathways, with TNF-alpha and other cytokines playing key roles in both intestinal and pulmonary inflammation. Some key points to consider include:

  • The lung involvement can occasionally precede gastrointestinal symptoms, as reported in a series of patients with Crohn disease, where respiratory problems developed postcolectomy in some cases 1.
  • The respiratory symptoms may be subtle and overlooked amid gastrointestinal complaints, so clinicians should maintain a high index of suspicion for pulmonary involvement in Crohn's patients presenting with unexplained respiratory symptoms.
  • Treatment typically involves corticosteroids and immunomodulators already used for intestinal disease management, with medications like infliximab often addressing both gastrointestinal and pulmonary manifestations simultaneously, as suggested by the improvement in patients with ILD and necrotic nodules who received systemic corticosteroid therapy 1. The variable histologic appearances in patients with Crohn disease are similar to those encountered in patients with ulcerative colitis, including chronic bronchiolitis with nonnecrotizing granulomatous inflammation, acute bronchiolitis associated with a neutrophil-rich bronchopneumonia and vague granulomatous features, cellular interstitial pneumonia with rare giant cells, and organizing pneumonia with focal granulomatous features 1.

From the Research

Interstitial Lung Diseases Associated with Crohn's Disease

  • Cryptogenic organizing pneumonia (COP) 2
  • Usual interstitial pneumonitis (UIP) 3
  • Bronchiolitis obliterans organizing pneumonia (BOOP) 3, 2
  • Eosinophilic pneumonia 3
  • Langerhan's granulomatosis 3
  • Non-necrotizing granulomatous inflammation mimicking sarcoidosis 4

Typical Age of Onset

  • The age of onset for these interstitial lung diseases in patients with Crohn's disease is not consistently reported in the provided studies.
  • However, one case report mentions a 29-year-old man with Crohn's disease who developed cryptogenic organizing pneumonia 2.
  • Another case report describes a 60-year-old female with a history of Crohn's disease who presented with interstitial lung disease mimicking sarcoidosis 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Crohn's disease-associated interstitial lung disease mimicking sarcoidosis: a case report and review of the literature.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.